ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Liver Outcome Monitoring Registry Consortium: Data and Preliminary Outcome Results

J. Case1, S. Kurian1, B. Barrick1, A. Robinson2, M. Prentice2, C. Marsh1

1Scripps Center for Organ and Cell Transplantation, La Jolla, CA, 2United Network for Organ Sharing Research Department, Richmond, VA

Meeting: 2020 American Transplant Congress

Abstract number: D-131

Keywords: Liver, Liver transplantation, Outcome

Session Information

Session Name: Poster Session D: Liver: Recipient Selection

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: The Liver Outcome Monitoring Registry (LOMR) is an online platform for collecting and monitoring liver outcome data of marginal and DCD organs to be compared to standard donors to provide an appropriate reference. Through the registry, optimum protocols can be drawn and implemented to enhance usage of these donor organs and improve overall post-transplant outcomes. The LOMR was launched collaboratively by our center and UNOS in August 2017 using data from Region 5. We present the data collection progress and preliminary results till August 2019.

*Methods: UNOS maintains the LOMR and has access to additional data (outside of the OPTN) submitted by each participating transplant center for inclusion in the LOMR. Currently there are seven participating transplant centers (Cedars-Sinai Medical Center, Scripps Green Hospital, Univ of California San Francisco, Keck Hospital of USC, University of California San Diego, Mayo Clinic Hospital Arizona and California Pacific Medical Center) with an additional eight transplant centers in the process of enrolling into the LOMR.

*Results: As of July 26th, 2019, the participating centers have completed 1,022 patient data forms with another 1,531 in process. When stratified by DCD/Liver Donor Risk Index (LDRI) as DCD, non-DCD (low LDRI) and non-DCD (high LDRI) there was a trend towards increased readmission rates in all three groups at 30, 90-days and 1-year post-transplant. There was also a trend towards decreased hepatic artery and portal vein thrombosis over time. There was an interesting pattern of return to the OR with a significant reduction between 30 days and 90 days followed by a significant increase at a year (p<0.001). When outcomes were stratified by % macro fat (0 -<20%, 20-<40% and >40%) there was a significant decrease in the return to OR for the <20% and >40% macro fat groups (p<0.0001 and 0.05). DCD livers had significantly higher return to OR within 30 days compared to both non-DCD groups (p<0.03 & 0.001). Interestingly, the non-DCD high LDRI group had significant portal vein thrombosis (p<0.005) within 30 days. Region 5 data showed of the DCD livers that were recovered from 01/01/16-03/06/2019, a large proportion (250/629; 40%) were not transplanted due to biopsy findings.

*Conclusions: The LOMR was designed with an objective to create a more effective, easily accessible tool to evaluate liver donor risk. Additional goals were to evaluate the short-term outcomes and benefits of short-term laboratory values and to include data from the Donor Management Goals. Our preliminary data suggest that a more critical and integrative assessment of short- and long-term post-transplant outcomes in the setting of high discard rates based purely on biopsy findings is critical. The LOMR data will help boost the usage of marginal and DCD organs to stem the supply vs. demand gap in liver transplantation.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Case J, Kurian S, Barrick B, Robinson A, Prentice M, Marsh C. The Liver Outcome Monitoring Registry Consortium: Data and Preliminary Outcome Results [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/the-liver-outcome-monitoring-registry-consortium-data-and-preliminary-outcome-results/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences